Archives - MSRD 2016

MSRD 2016 Coordinators

Talha, Weining, Sally, Yiwen and Michael

 

 

Keynote Speaker

Dr. David Malkin, MD 

Dr. David Malkin
Dr. Malkin received his medical degree from the University of Toronto in 1984 and completed his residency in paediatrics and paediatric hematology/oncology at The Hospital for Sick Children in Toronto. He completed post-doctoral research training in molecular genetics at Massachusetts General Hospital, Harvard University, where he discovered the link between germline mutations on the p53 tumor suppressor gene and the Li-Fraumeni cancer susceptibility syndrome. Dr. Malkin returned to Canada to accept a faculty position at SickKids and University of Toronto. 
Dr. Malkin is currently a clinician-scientist and paediatric oncologist in the Division of Hematology/Oncology and Director of the Cancer Genetics program at SickKids as well as a Senior Scientist in the Genetics & Genome Biology Program in the SickKids Research Institute. He is a Professor in the Departments of Paediatrics and Medical Biophysics in the Faculty of Medicine at the University of Toronto. Dr. Malkin has an active clinical oncology practice at the Hospital and both undergraduate and post-graduate teaching responsibilities there as well as at the University. 
Dr. David Malkin
His research interests are closely integrated with his clinical field of expertise. Specifically, his research program focuses primarily on genetic mechanisms of childhood cancer susceptibility, and the genetic basis of childhood sarcomas (cancers of bone, muscle and other soft tissues). His research team was the first to demonstrate that highly variable regions of DNA, termed copy number variations, are found in excess in the blood of some people, both children and adults, at very high risk of developing cancer, and may represent the earliest genetic changes that ultimately lead to development of cancer. Recently, his work has focused on application of this genetic/genomic information to develop rational clinical surveillance and treatment guidelines for children and adults deemed at genetic ‘high risk’ for cancer. In his sarcoma work, Dr. Malkin has studied the molecular and cell biology pathways that are associated with the development and progression of these cancers, and has identified molecules that might represent viable targets for novel drug therapies.
 

Oral Abstract Presenters

Johnny-Wei Bai, MD 1T8 Candidate.
Abstract Title: Cardiovascular Disease Guideline Adherence and Statin Use in Longstanding Type 1 Diabetes: Results From The Canadian Study of Longevity in Diabetes Cohort 
 
Karan Josh Abraham, MD/PhD Candidate. 
Abstract Title: Suppression of RNA-DNA Hybrids - Towards a Novel and Coherent Mechanism Governing Repetitive DNA Stability, Aging, and Neurodegenration  

 

Omri A. Arbiv CREMS Summer Research Scholar and MD 1T6 Candidate. 
Abstract Title: Risk Factors for Hematopoietic Stem Cell Transplantation in Inherited Bone Marrow Failure Syndromes 
 

Poster Category Winners

Basic Science: Paymon Azizi
Clinical Science: Alexander Koven
Public Health: Elise Fryml
Quality Improvement: Kyle Eastwood
Medical Education: Sydney McQueen
Health Services: Xiao Xiong Yu
First Year Award: Haniya Khan

Conference Booklet

Please see this link
 

Photos

Click here to check out the photos from MSRD 2016
 

Acknowledgements

  • Participants - they are the foundation of this conference and key to the future innovation in healthcare.
  • Dr. Neil Sweezey, CREMS Program Director
  • Ms. Lisa Charette, CREMS Program Coordinator
  • Ms. Sandy McGugan, Administrative Manager of MD/PhD Program 
  • Desmond She and Team Lab Coat (website development)
  • Justin Lam and Shara Nauth (photographers)
 

Sponsors

We would like to thank the following organizations for their contribution to MSRD 2016:

Ontario Medical Association Peters-Boyd Academy   UofT Medical Society